JP2007513056A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513056A5 JP2007513056A5 JP2006525105A JP2006525105A JP2007513056A5 JP 2007513056 A5 JP2007513056 A5 JP 2007513056A5 JP 2006525105 A JP2006525105 A JP 2006525105A JP 2006525105 A JP2006525105 A JP 2006525105A JP 2007513056 A5 JP2007513056 A5 JP 2007513056A5
- Authority
- JP
- Japan
- Prior art keywords
- oxcarbazepine
- appropriate
- placebo
- usefulness
- blind
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CTRLABGOLIVAIY-UHFFFAOYSA-N oxcarbazepine Chemical compound C1C(=O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 CTRLABGOLIVAIY-UHFFFAOYSA-N 0.000 description 2
- 229960001816 oxcarbazepine Drugs 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0320637A GB0320637D0 (en) | 2003-09-03 | 2003-09-03 | Organic compounds |
| US53737804P | 2004-01-16 | 2004-01-16 | |
| PCT/EP2004/009797 WO2005020968A2 (en) | 2003-09-03 | 2004-09-02 | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007513056A JP2007513056A (ja) | 2007-05-24 |
| JP2007513056A5 true JP2007513056A5 (https=) | 2007-10-18 |
Family
ID=34276821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525105A Pending JP2007513056A (ja) | 2003-09-03 | 2004-09-02 | 糖尿病性神経因性疼痛の処置および睡眠の改善のためのオキシカルバゼピンの使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20060270658A1 (https=) |
| EP (1) | EP1663247B1 (https=) |
| JP (1) | JP2007513056A (https=) |
| KR (1) | KR20060118426A (https=) |
| AT (1) | ATE446759T1 (https=) |
| AU (1) | AU2004268381B2 (https=) |
| BR (1) | BRPI0414112A (https=) |
| CA (1) | CA2537060A1 (https=) |
| DE (1) | DE602004023861D1 (https=) |
| IL (1) | IL173822A0 (https=) |
| IS (1) | IS8373A (https=) |
| MA (1) | MA28036A1 (https=) |
| MX (1) | MXPA06002392A (https=) |
| NO (1) | NO20061515L (https=) |
| RU (1) | RU2369393C2 (https=) |
| SG (1) | SG146631A1 (https=) |
| TN (1) | TNSN06072A1 (https=) |
| WO (1) | WO2005020968A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| ES2360423T3 (es) * | 2006-04-26 | 2011-06-03 | Supernus Pharmaceuticals, Inc. | Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal. |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| KR102486435B1 (ko) | 2022-04-25 | 2023-01-10 | 주식회사 제이비플랜트 | 산업용 냉동기기의 친환경 패널의 제조 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH500196A (de) | 1969-03-10 | 1970-12-15 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Azepinderivaten |
| US4353887A (en) | 1979-08-16 | 1982-10-12 | Ciba-Geigy Corporation | Divisible tablet having controlled and delayed release of the active substance |
| CO4920215A1 (es) | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
| GB9925962D0 (en) * | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
| GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
| GB0128674D0 (en) * | 2001-11-30 | 2002-01-23 | Boots Co Plc | Treatment of sleep disorders and the like |
| CA2497780A1 (en) * | 2002-10-17 | 2004-04-29 | Novartis Ag | Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors |
-
2004
- 2004-09-02 EP EP04764755A patent/EP1663247B1/en not_active Expired - Lifetime
- 2004-09-02 SG SG200806736-5A patent/SG146631A1/en unknown
- 2004-09-02 BR BRPI0414112-1A patent/BRPI0414112A/pt not_active IP Right Cessation
- 2004-09-02 RU RU2006110550/15A patent/RU2369393C2/ru not_active IP Right Cessation
- 2004-09-02 JP JP2006525105A patent/JP2007513056A/ja active Pending
- 2004-09-02 DE DE602004023861T patent/DE602004023861D1/de not_active Expired - Lifetime
- 2004-09-02 CA CA002537060A patent/CA2537060A1/en not_active Abandoned
- 2004-09-02 WO PCT/EP2004/009797 patent/WO2005020968A2/en not_active Ceased
- 2004-09-02 AT AT04764755T patent/ATE446759T1/de not_active IP Right Cessation
- 2004-09-02 MX MXPA06002392A patent/MXPA06002392A/es not_active Application Discontinuation
- 2004-09-02 US US10/570,340 patent/US20060270658A1/en not_active Abandoned
- 2004-09-02 AU AU2004268381A patent/AU2004268381B2/en not_active Ceased
- 2004-09-02 KR KR1020067004340A patent/KR20060118426A/ko not_active Ceased
-
2006
- 2006-02-20 IL IL173822A patent/IL173822A0/en unknown
- 2006-03-02 TN TNP2006000072A patent/TNSN06072A1/en unknown
- 2006-03-10 MA MA28869A patent/MA28036A1/fr unknown
- 2006-03-24 IS IS8373A patent/IS8373A/is unknown
- 2006-04-03 NO NO20061515A patent/NO20061515L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535814A5 (https=) | ||
| JP2011522896A5 (https=) | ||
| IL259851A (en) | Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders | |
| EP2545939A3 (en) | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring | |
| NZ711283A (en) | Compositions and methods for lowering triglycerides without raising ldl-c levels | |
| JP2007527914A5 (https=) | ||
| SI2142193T1 (sl) | 1-(2-(2,4-dimetilfenilsulfanil)fenil)piperazin kot spojina s kombiniranim vnosom serotonina, 5-ht3 in 5-hta1 aktivnostjo za zdravljenje boleäśine ali ostalih simptomov pri depresiji v zvezi s spanjem in kognicijo | |
| EP1979324A4 (en) | IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF COGNITIVE DISORDER, MORBUS ALZHEIMER, NEURODEGENERATION AND DEMENTIA. | |
| JP2010059183A5 (https=) | ||
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| IL197420A (en) | Polymorphic form of 4 - [3 - (4 - cyclopropanecarbonyl - piperazine - 1 - carbonyl) - 4 - fluoro - benzyl] - h2 - phthalazine - 1 - on, methods of preparation, a pharmaceutical preparation containing it and uses in this form to prepare drugs for the treatment of the human body | |
| IL245489A0 (en) | New 1-aryl-3-azabicyclo[0.1.3]hexanes, their preparation and their use for the treatment of neuropsychotic disorders | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| NO2014028I2 (no) | Glukopyranosyl-substituerte benzenderivater, fremgangsmåte for fremstilling av disse, fysiologisk akseptable salter av slike forbindelser, medikamenter inneholdende slike forbindelser og kombinasjoner med andre aktive substanser samt deresanvendelse for fremstilling av medikamenter for behandling av sykdom | |
| JP2007513056A5 (https=) | ||
| JP2008266291A5 (https=) | ||
| TW200800977A (en) | A new salt | |
| JP2009502937A5 (https=) | ||
| WO2006138317A3 (en) | Dosage regimen for prasugrel | |
| WO2006138571A3 (en) | Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance | |
| JP2006342148A5 (https=) | ||
| IL190273A0 (en) | Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake | |
| MX2008015323A (es) | Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion. | |
| WO2007145993A3 (en) | Modified compositions and methods for enhancing brain function | |
| UA40964U (uk) | Лікарський препарат у формі таблеток |